Open access · US-GOV via ClinicalTrials.gov Clinical trial

Open Label Study for the Use of Plasmapheresis for Treatment of Age-Related Frailty

Authors not listed

Neurological Associates of West Los Angeles · 2021

Dysbiosis Plasma dilution / young plasma Human Randomized controlled trial

Abstract

This study is designed to evaluate the efficacy of albumin-infused plasmapheresis, using the Fresenius Kabi 'Amicus' apheresis machine, among patients with age-related frailty characterized by reduced physical, cognitive and immunological functioning. Additionally, this study is designed to evaluate the safety and tolerability of repeated plasmapheresis treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-24 MST

Cite this

APA

Anonymous. (2021). Open Label Study for the Use of Plasmapheresis for Treatment of Age-Related Frailty. <em>Neurological Associates of West Los Angeles</em>. https://clinicaltrials.gov/study/NCT05054894

Vancouver

Anonymous. Open Label Study for the Use of Plasmapheresis for Treatment of Age-Related Frailty. Neurological Associates of West Los Angeles. 2021.

BibTeX

@misc{anon2021OpenLa, title = {Open Label Study for the Use of Plasmapheresis for Treatment of Age-Related Frailty}, author = {Anonymous}, journal = {Neurological Associates of West Los Angeles}, year = {2021}, }